DrugPatentWatch Database Preview➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing
« Back to Dashboard
The generic ingredient in TRIFERIC is ferric pyrophosphate citrate. There are twenty drug master file entries for this compound. Two suppliers are listed for this compound. Additional details are available on the ferric pyrophosphate citrate profile page.
Generic Entry Opportunity Date for 208551
*The generic entry opportunity date is the latter of the last compound-claiming patent and the last regulatory exclusivity protection. Many factors can influence early or later generic entry. This date is provided as a rough estimate of generic entry potential and should not be used as an independent source.
Pharmacology for NDA: 208551
|Mechanism of Action||Phosphate Chelating Activity |
Suppliers and Packaging for NDA: 208551
Profile for product number 001
|Active Rx/OTC/Discontinued:||RX||Dosage:||FOR SOLUTION;INTRAVENOUS||Strength||272MG IRON/PACKET|
|Approval Date:||Apr 25, 2016||TE:||RLD:||Yes|
|Patent:||Start Trial||Patent Expiration:||Apr 17, 2029||Product Flag?||Substance Flag?||Delist Request?|
|Patent:||Start Trial||Patent Expiration:||Sep 8, 2027||Product Flag?||Substance Flag?||Delist Request?|
Complete Access Available with Subscription